Sareum Share Forecast, Price & News

Sareum (LON:SAR) Frequently Asked Questions

What stocks does MarketBeat like better than Sareum?

Wall Street analysts have given Sareum a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sareum wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Sareum's next earnings date?

Sareum is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.
View our earnings forecast for Sareum.

How has Sareum's stock been impacted by COVID-19 (Coronavirus)?

Sareum's stock was trading at GBX 0.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SAR shares have increased by 1,949.2% and is now trading at GBX 6.25.
View which stocks have been most impacted by COVID-19.

Who are Sareum's key executives?

Sareum's management team includes the following people:

• Dr. Tim J. Mitchell, Founder, CEO & Exec. Director (Age 61, Pay $184.85k)
• Dr. John C. Reader Ph.D., Founder, Chief Scientific Officer & Exec. Director (Age 54, Pay $183.44k)
• Mr. Anthony Bunn F.C.M.A., FCMA, Sec.

Who are some of Sareum's key competitors?

Some companies that are related to Sareum include Beximco Pharmaceuticals (BXP), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), ECO Animal Health Group (EAH), Futura Medical (FUM), Avivagen (VIV), Cathay International Holdings Limited (CTI.L) (CTI), N4 Pharma (N4P), Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group (MYX), Medical Developments International (MVP), Opthea (OPT) and Otsuka (OTSKY).
View all of SAR's competitors.

What other stocks do shareholders of Sareum own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP), Madagascar Oil (MOIL), Summit Therapeutics (SMMT), Rockhopper Exploration (RKH) and Anglo Pacific Group (APF).

What is Sareum's stock symbol?

Sareum trades on the London Stock Exchange (LON) under the ticker symbol "SAR."

How do I buy shares of Sareum?

Shares of SAR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sareum's stock price today?

One share of SAR stock can currently be purchased for approximately GBX 6.25.

How much money does Sareum make?

Sareum has a market capitalization of £210.36 million and generates £47,204.00 in revenue each year.

How many employees does Sareum have?

Sareum employs 5 workers across the globe.

What is Sareum's official website?

The official website for Sareum is www.sareum.co.uk.

Where are Sareum's headquarters?

Sareum is headquartered at Unit 2A Langford Arch, London Road, Pampisford, CAMBRIDGE, CB22 3FX, United Kingdom.

How can I contact Sareum?

Sareum's mailing address is Unit 2A Langford Arch, London Road, Pampisford, CAMBRIDGE, CB22 3FX, United Kingdom. The company can be reached via phone at +44-1223-497700.